Papers 4

  1. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Porteous DJ et al., Gene Ther. 1997 Mar;4(3):210-8.
  2. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Caplen NJ et al., Nat Med. 1995 Jan;1(1):39-46.
  3. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy.
    McLachlan G et al., Gene Ther. 1995 Nov;2(9):614-22.
  4. Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.
    McLachlan G et al., Gene Ther. 1996 Dec;3(12):1113-23.

 

Purifying mRNA from tissue samples.